News Releases
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating VectivBio Holding AG Buyout
Wilmington, Delaware–(Newsfile Corp. – May 22, 2023) – Rigrodsky Law, P.A. is investigating VectivBio Holding AG ("VectivBio") (NASDAQ: VECT) regarding…
Wilmington, Delaware–(Newsfile Corp. – May 22, 2023) – Rigrodsky Law, P.A. is investigating VectivBio Holding AG (“VectivBio”) (NASDAQ: VECT) regarding possible breaches of fiduciary duties and other violations of law related to VectivBio’s agreement to be acquired by Ironwood Pharmaceuticals, Inc. Under the terms of the agreement, VectivBio shareholders will receive $17.00 per share in cash.
To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-vectivbio-holding-ag.
To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: info@rl-legal.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/167009
nasdaq
nasdaq-vect
vectivbio-holding-ag
vectivbio holding ag
press-release
nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) Announces an Expansion of its YMI Validation Project
Calgary, Alberta – TheNewswire – October 17, 2023 – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) announces an expansion…
Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM – An Important Commercial Milestone Achieved
TeloView Analyses Telomeres to Accurately Predict and Characterize Multiple MyelomaToronto, Ontario–(Newsfile Corp. – October 17, 2023) – Telo Genomics…
NervGen Pharma Appoints John Ruffolo to Board of Directors
Extensive experience in private equity, venture capital and advising high growth, innovative companiesBrings personal experience and knowledge of spinal…
